Toxicology studies of a superparamagnetic iron oxide nanoparticle in vivo

Advanced Materials Research

Volumn 47-50 PART 2, Issue , 2008, Pages 1097-1100

  Liu, Shiyuan ^a   Han, Yu ^b   Yin, Longping ^b   Long, Ling ^b   Liu, Rui ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

AAS; Nanoparticle; SPIO; Toxicology

Indexed keywords

BIOLOGICAL ORGANS; LIVER; MATERIALS SCIENCE; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; SUPERPARAMAGNETISM; TOXICITY; FUNCTIONAL MATERIALS; IRON; MAMMALS; SOFTWARE TESTING;

AAS; CLINICAL PRACTICES; CLINICAL SIGNS; HAZARD POTENTIALS; IN-VIVO; LOW DOSING; LOW TOXICITIES; SPIO; SPIO NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TOXICOLOGY; HAZARD POTENTIAL; LOW TOXICITY;

IRON OXIDES;

EID: 56349172565     PISSN: 10226680     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (5)

1. Jun Ho J, Jae J, Sang K, et al. Twenty-Eight-Day Inhalation Toxicity Study of Silver Nanoparticles in Sprague-Dawley Rats. Inhal Toxic.2007;19:857- 871.
2. Sun YD, Zheng M, Chen W, et al. Nanotechnology challenge: safety of nanomaterials and nanomedicines. Asian J of PD and PK.2007;7:17-31.
3. Oswald P, Clement O, Chambon C, et al. Liver-positive enhancement after injection of Superparamagnetic nanoparticles: respective role of circulating and uptaken particles. Magn Reson Imaging. 1997;15:1025-1031.
4. Benderbous S, Corot C, Jacobs P, et al. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol. 1996;3:S292-S294.
5. Philippe B, Howard B, Bruno B, et al. Preclinical safety and pharmacokinetic profile of Ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Inve Radiol.2006;41:313-324.